09-10-2025
Lysoveta named a winner of the NIE New Ingredient Awards in Healthy Aging
We’re thrilled to announce that Aker BioMarine’s Lysoveta® has been named a winner in the Healthy Aging category in...
22-09-2025
Aker to Promote Antarctic MPA Proposal at Clinton Global Initiative
Oslo / New York, September 2025 – Aker BioMarine and Aker QRILL Company will take part in the Clinton Global Initiative in...
19-09-2025
The Superpowers of Krill: “The genome suggests species is extremely adaptable”
An interview with Nils Hoem, Chief Scientist at Aker BioMarine Antarctic krill may be small, but genetically it is a giant....
17-07-2025
Krill oil supplementation helps preserve muscle strength and mass during diet-induced weight loss
Oslo, July 17 2025: A new study, led by the University of Glasgow’s School of Medicine, Dentistry and Nursing, shows that...
11-07-2025
Continued positive momentum in the second quarter with double-digit revenue growth
Highlights second quarter 2025: • Q2 revenue reached USD 55.3 million, a 12% increase year-over-year, with adjusted EBITDA...
26-06-2025
New Platform Unlocks 20 Years of Antarctic Krill Research
A new digital platform with 20 years of research on Antarctic krill and the Southern Ocean has now been launched by Aker...
29-05-2025
Aker BioMarine Appoints Bob Nelson as General Manager to its Houston Manufacturing Facility
Through teamwork, performance, and visionary leadership, Nelson sets his sights on “Building for the Future”
08-05-2025
Aker BioMarine signs agreement for Lysoveta clinical trial
Oslo, 30 April 2025 – Aker BioMarine has signed an agreement with leading clinical research organization KGK Science Inc.,...
30-04-2025
Aker BioMarine Delivers Strong Start to 2025 with Revenue and Earnings Growth
Oslo, 30 April 2025 – Aker BioMarine today reported its financial results for the first quarter of 2025, delivering solid...